İHALE DÜNYASI
İHALE DÜNYASI
Levomefolate Calcium/Algal Powder (7.5 mg-90.314mg) is an orally administered prescription dietary supplement specifically formulated for the dietary management of patients with unique nutritional needs requiring increased folate levels. Levomefolate Calcium/Algal Powder (7.5 mg-90.314mg) should be administered under the supervision of a licensed medical practitioner. Each opaque orange cap and opaque white body capsule contains the following dietary ingredient: Supplement Facts Serving Size: 1 capsule Servings per Container: 90 (NDC ? 76439-323-90) Amount per Serving % Daily Value L-Methylfolate Calcium contains less than 1% d-methylfolate. 7.5 mg Daily Value not established for patients with unique nutritional needs who are in need of supplementation as directed by a licensed medical practitioner. Algal Powder From algae derived from schizochytrium sp, ulkenia sp, and/or crypthecodinium cohnii strains 90.314 mg Other Ingredients May Contain: Gelatin, Microcrystalline Cellulose, Magnesium Stearate, Silicon Dioxide, Sodium Citrate Dihydrate, Ascorbic Acid, Glutathione, Citric Acid, Titanium Dioxide, FD & C Yellow #6, Water and other ancillary ingredients as needed to ensure product stability. Since additives, preservatives, bioavailability enhancers, colors and/or flavors of natural origin, etc. are preferred over synthetics, it may be the case that product color, appearance and/or taste may vary slightly over time; and it may be necessary to substitute excipients during the manufacturing process as needed to preserve product appearance and continuity in order to avoid confusion in the marketplace and ensure the highest therapeutic target, safety and quality. CAUTION: Contains FD&C Yellow #6, milk and soy.
Levomefolate Calcium/Algal Powder (7.5 mg-90.314mg) is indicated for the distinct nutritional requirements of patients in need of advanced folate supplementation-specifically suboptimal folate or maintenance-level needs, as determined by a licensed medical practitioner. Levomefolate Calcium/Algal Powder (7.5 mg-90.314mg) should be administered under the supervision of a licensed medical practitioner.
The usual adult dose is 1 capsule, daily with or without food or as directed by a licensed medical practitioner.
This product is contraindicated in patients with a known hypersensitivity to any of the components contained in this product. This product is contraindicated for individuals with conditions for which any of the ingredients are contraindicated.
Allergic reactions have been reported following the use of oral and parenteral folate. Mild transient diarrhea, polycythemia vera, itching, transitory exanthema and the feeling of swelling of the entire body has been associated with cobalamin. Nausea, vomiting, diarrhea, transient skin rash, flushing, epigastric pain, and constipation have been associated with acetylcysteine. Call your medical practitioner about side effects.
Caution is recommended in patients with a history of bipolar illness. Mood elevation is possible in this population. Caution is also recommended in patients taking anticonvulsant medications as folate may interfere with anticonvulsant medication, and may lower seizure threshold. Furthermore, it has been reported that anticonvulsant medications interfere with folate metabolism, but the exact action is unclear; therefore caution is recommended with patients in this therapeutic group. Folinic acid may enhance the toxicity of fluorouracil. Deaths from severe enterocolitis, diarrhea, and dehydration have been reported in elderly patients receiving weekly formyl-THF and fluorouracil. Concomitant granulocytopenia and fever were present in some but not all of the patients. The concomitant use of formyl-THF with trimethoprim-sulfamethoxazole for the acute treatment of Pneumocystis carinii pneumonia in patients with HIV infection was associated with increased rates of treatment failure and mortality in a placebo controlled study. 13 Patients undergoing cancer treatment should consult their licensed medical practitioner for advice.
